Telford, Pa. – February 2, 2016 – Secant Medical releases new study results for a series of Regenerez®-based materials which exhibit >99.99% antibacterial activity against a range of bacterial species. Results from JIS Z 2801 antimicrobial activity and efficacy test demonstrate the antibacterial properties of Regenerez, with respect to commonly occurring organisms in surgical site infections; including MRSE, MRSA, S. epidermidis and P. aeruginosa, with log reduction values of >3.5.
“We are excited by the antibacterial activity of Regenerez,” said Jeremy Harris, Research Director at Secant Medical. “With tunable mechanical properties and the ability to inhibit bacterial growth, this material may address several critical biomedical engineering needs of scientists, researchers and engineers.”
Regenerez resin is a fully-synthetic, bioresorbable, surface-eroding polymer, composed of poly(glycerol sebacate). It is synthesized from the naturally occurring metabolites glycerol and sebacic acid using Secant Medical’s proprietary manufacturing process to produce a consistent, quality product, which is detailed in a FDA master file.
Secant Medical will be exhibiting at MD&M West, February 9-11, 2016, at booth #2371. The company’s team will present the Regenerez study results as well as showcase a variety of polymeric and metallic biomedical structures that can be used in the design of medical devices for cardiovascular, general surgery, neurovascular and orthopedic indications.
About Secant Medical: Secant Medical designs and manufactures biomedical textiles and advanced biomaterials for medical devices and pharmaceuticals. Employing medical fabric engineering technologies, we blend polymeric, metallic and resorbable biomaterials to create custom, high-performance structures that are used in the cardiovascular, general surgery, neurovascular, orthopedic and regenerative medicine fields. Built on a 70-year history, we’re committed to the future of biomaterials and their role in the healing process and are actively engaged in research partnerships to advance next-generation biomaterial development. Secant Medical is a business unit of Fenner PLC, a worldwide leader in reinforced polymer engineering headquartered in Yorkshire, England.